FDA inspection
Frontida BioPharm Inc: FDA inspection ending Jan 12, 2000
FDA inspection 10042 · Official Action Indicated (OAI) · Philadelphia, PA
Key facts
| Inspection ID | 10042 |
|---|---|
| Firm | Frontida BioPharm Inc |
| FEI number | 2523348 |
| Address | 1100 Orthodox St |
| City | Philadelphia |
| State | PA |
| ZIP | 19124-3168 |
| Fiscal year | 2000 |
| Inspection end date | Jan 12, 2000 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data